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the blood units testing positive for
hepatitis B surface (13%), HIV, and
HTLV, which accounted for nearly
one third of all donations in 2001.
These findings argue in favor of main-
taining a roster of regular, seronega-
tive donors to save numbers of blood
units. 
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Prosthetic Valve
Endocarditis due to
Kytococcus
schroeteri
To the Editor: Bacteria belonging
to the former genus Micrococcus, the
so-called micrococci, are usually
regarded as contaminants from skin
and mucous membranes. Neverthe-
less, micrococci have been reported as
emerging pathogens in immunocom-
promised patients and have been
described in severe infections (1–4).
We describe what is, to our knowl-
edge, the first case of prosthetic valve
endocarditis caused by the newly
described micrococcal species,
Kytococcus schroeteri. Accurate iden-
tification of this species is of particu-
lar importance as kytococci—in con-
trast to other micrococcal species—
are frequently resistant to penicillin
and oxacillin (5).
A 34-year-old woman was admit-
ted to the hospital with acute, severe
aortic regurgitation, attributable to a
dissection of both the ascending and
descending aorta, which extended into
the supraaortic and iliac arteries.
Immediate surgical intervention was
performed by implantation of an aor-
tic arch (St. Jude Medical Inc., St.
Paul, MN) conduit and reimplantation
of the supraaortic arteries. Ten weeks
later, the patient was admitted to the
hospital because of fever of 39°C.
Laboratory studies showed a leuko-
cyte count of 15.3 x 109/L with 87%
neutrophils and elevated C-reactive
protein (180 mg/L). Transesophageal
echocardiography and computed
tomography suggested an abscess
next to the prosthesis and showed
vegetations on the prosthetic valve,
which suggested endocarditis. Blood
cultures yielded gram-positive cocci
on four separate occasions during an
11-day period. Treatment, performed
according to the antimicrobial suscep-
tibilities of the isolates, consisted of
vancomycin, gentamicin, and
rifampin for 21 days. Within 1 week,
the fever resolved and the leukocyte
count returned to normal. Four days
after antimicrobial therapy was initi-
ated, right-sided hemiparesis and
aphasia, thought to be due to an
embolic cerebral stroke, developed.
After those events, the aortic arch
prosthesis was replaced without fur-
ther complications.
Blood culture specimens were
injected into BACTEC Plus culture
vials for aerobic and anaerobic cul-
tures and processed in BACTEC 9240
blood culture system (Becton
Dickinson, Cockeysville, MD).
Growth was detected in four different
aerobic blood cultures after incubation
of 3 to 5 days. Aerobic subcultures on
Columbia agar supplemented with 5%
sheep blood showed tiny, muddy-yel-
low colonies without hemolysis after
24 h of incubation. After 48 h, the size
of colonies increased, a feature typical
of K. sedentarius, which is known to
grow slightly more slowly than other
members of the former Micrococcus
genus. No or very weak reactions
were found after 24 h incubation when
the ID32 STAPH ATB gallery
(bioMérieux Vitek, Hazelwood, MO)
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was used. After 48 h, the reactions
with this gallery resembled those of
M. luteus or M. lylae. The probability
of identification was indicated as
99.0% (M. luteus, T index of 0.77) for
the profile 000003000 and 51.8% (M.
lylae, T index of 0.98) and 47.2% (M.
luteus, T index of 0.93), respectively,
for the profile 000001000. When the
ID-GPC card (VITEK 2, bioMérieux
Vitek) was used, a poor selectivity
was observed (M. luteus, T index
0.95;  Kocuria rosea, T index 0.84).
All isolates were resistant to oxacillin,
penicillin, fosfomycin, ampicillin, and
erythromycin and susceptible to van-
comycin, teicoplanin, gentamicin,
netilmicin, chloramphenicol, imipen-
em, rifampin, tetracycline, amoxi-
cillin/clavulanate, and ciprofloxacin,
as determined by disk diffusion
method performed on Mueller-Hinton
agar.
When arbitrarily primed-poly-
merase chain reaction with prolonged
ramp times (6) was used, isolates
were shown to be clonal, representing
one strain (DSM 13884T). Since
colony formations, resistance pattern,
and growth rate of this strain did not
correspond with the species identifi-
cation, as obtained by automated sys-
tems, further phenotypic and molecu-
lar studies were conducted, confirm-
ing the micrococcal nature of this
unknown strain and justifying the
classification as a distinct species,
Kytococcus schroeteri sp. nov. (7).
In addition to the Micrococcus
genus, bacteria belonging to the for-
mer genus Micrococcus were recently
divided into the genera Kocuria,
Nesterenkonia,  Kytococcus, and
Dermacoccus, followed by rearrange-
ment into two families (Micrococ-
caceae, Dermatophilaceae) of the
suborder Micrococcineae (5).
The traditional identification of the
micrococci is based on their suscepti-
bility to lysozyme and bacitracin and
their resistance to lysostaphin and
nitrofurantoin, in contrast to staphylo-
cocci, which display the opposite pat-
tern. In automated identification sys-
tems, micrococci are included only in
a limited manner. A prospective study
showed an overall accuracy of results
of 61.0% concerning Micrococcus
species when the STAPH-IDENT
strip (bioMérieux) was compared
with conventional identification
methods (8).
Micrococcal species are ubiquitous
inhabitants of the human skin and
mucous membranes and are usually
disregarded as contaminants in clini-
cal specimens. Yet, various severe
infections such as arthritis, central
nervous system infection, pneumonia,
peritonitis, hepatic abscess, endo-
carditis, and nosocomial blood stream
infections have been documented
(1,3,4,9). Since early reports of endo-
carditis caused by gram-positive cocci
that appear in tetrads and packets
often did not reliably differentiate
between micrococci and phenotypi-
cally similar microorganisms, such as
coagulase-negative staphylococci, the
frequency of micrococcal endocarditis
is difficult to ascertain and might be
underestimated. However, several
cases of endocarditis attributable to M.
lylae, M. luteus, K. sedentarius, and
unspecified micrococci have been
reported (1). 
Regarding micrococci, data on
antimicrobial susceptibilities are
rare, and often the species affiliation
remains unclear. In contrast to most
micrococcal isolates, K. sedentarius
isolates, as well as those reported
here, are resistant to penicillin G and
oxacillin. In the patient we describe,
therapy was performed with van-
comycin, gentamicin, and rifampin,
resulting in bacteriologic eradication
and clinical cure. However, a gener-
ally accepted therapeutic regime for
severe infections with kytococcal
species has not yet been defined.
Concerning micrococci other than
kytococci, a combination of rifampin
with ampicillin has been effective
(3). Successful treatment has also
been achieved with vancomycin,
clindamycin, penicillin, gentamicin,
or a combination of these agents.
Overall, rifampin shows the highest
activity against all micrococcal
species (10).
This report is the first case of K.
schroeteri causing endocarditis on an
artificial heart valve. The repeated
recovery of this species from blood
cultures strongly suggests a patho-
genic role. We conclude that isola-
tion of micrococci from blood speci-
mens cannot always be disregarded
as etiologically irrelevant. Results
performed by automated identifica-
tion systems should be interpreted
with caution if micrococci are
involved.
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When Is a
Reservoir Not a
Reservoir? 
To the Editor: Some 80% of para-
sitic infections of humans are
zoonoses (1). These infections are
caused by multihost parasites for
which the reservoir of infection
depends on hosts other than Homo
sapiens. But what is a reservoir of
infection? 
Haydon et al. (2) proposed a new
series of definitions in connection
with multihost pathogens, in which a
target host is the host of interest in a
particular context. The reservoir of
infection included, for these authors,
all hosts, whether incidental or not,
that are epidemiologically connected
to (i.e., contribute to transmission to)
the target host.
The availability of three terms—
reservoir, reservoir of infection, and
reservoir host—frequently used inter-
changeably, leads to confusion. This
confusion is, in part, what prompted
me (3) to slightly redefine a reservoir
(of infection) as an ecologic system in
which an infectious agent survives
indefinitely. Such a system includes
all the component host populations,
including that of any intermediate
host or vector, in the context of any
environmental component, and any
quantitative requisite such as critical
community size, which is required to
maintain the agent indefinitely. 
Vertebrate hosts that form an
essential part of the system are reser-
voir hosts, though whether a whale or
a fish is the reservoir host of Anisakis
species can be a matter of debate. A
host that becomes infected, but is not
required for the maintenance of the
population of a pathogen, can useful-
ly be called an incidental host.
(Accidental host is frequently used,
but this is arguably a teleological term
and therefore undesirable.) For inci-
dental hosts that transmit pathogens
from a reservoir to another incidental
host, analogous to a pipe leading from
a water reservoir, Garnham (4) coined
the useful term “liaison host.”
Haydon et al. dismiss my defini-
tion on two grounds. First, I exclude
liaison hosts from the reservoir. This
distinction is valid and could be
argued either way, but I suggest that
the pipes leading from a reservoir do
not form part of the reservoir and that
it is both conceptually and practically
important to distinguish liaison hosts
from reservoir hosts. The second
objection is that many pathogens
depend on the presence of several host
species, at any given stage in the life
history, for their maintenance. This
concept is clearly considered in my
article: together, such hosts collec-
tively constitute part of the reservoir
system, though no single one may be
the reservoir host in its own right.
In good scientific English, each
term should have a precise definition,
and synonyms should be avoided. The
Oxford English Dictionary (OED) (5)
definitions of reservoir generally refer
to a place or container used for the
collection and storage of water, other
fluids, or even solid material.
The OED definition of reservoir as
a medical term is. “Apopulation which
is chronically infested with the
causative agent of a disease and can
infect other populations.” While one
might argue with the terms chronically,
infested, and the infection of popula-
tions, this definition captures the usual
sense in which reservoir host is used.
The quotations given in OED are
more helpful. The earliest one given
for reservoir in a medical context is
from 1937, “For the continuous exis-
tence of a disease there must be some
reservoir of infection… The most
important reservoirs of infection are
human or animal cases or carriers.
Plants may be the reservoir of infec-
tion in some of the mycoses.”
However, according to OED, the com-
pound term “reservoir host” was used
earlier, in 1913, “The monkey is most
probably the normal reservoir host [for
Physaloptera mordens].”
The main conceptual difference
between the proposal of Haydon et al.
and my own is that mine is more gen-
eralized: for a given pathogen in a
given place, there is a single reservoir.
The proposal of Haydon et al. is more
limited to practical considerations: the
reservoir for one target host may not
be the same as that for another target
host in the same place.
The most important contribution
of these two publications is that they
raise an issue that has confused the lit-
erature for many years. Parasito-
logists, virologists, and bacteriolo-
gists should agree on a consensus set
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